StockData
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. (INBS) stock

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3058% below fair value
$1.51−0.03 (-1.95%)

Close on Nov 19, 2026Market cap $4.57MP/E –Yield –

Intelligent Bio Solutions free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Intelligent Bio Solutions's free cash flow for the twelve months ending Jun 30, 2026 was -$12.05M. For fiscal 2026 it was -$12.05M.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$12.05M–
FY2025Jun 30, 2025-$9.91M–
FY2024Jun 30, 2024-$9.79M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$3.18M–
Q3 FY2026CQ1 2026Mar 31, 2026-$4.32M–
Q2 FY2026CQ4 2025Dec 31, 2025-$1.64M–
Q1 FY2026CQ3 2025Sep 30, 2025-$2.92M–

More Intelligent Bio Solutions figures

See a number that looks wrong?